APO Research
Talk to an analyst

APO RESEARCH · REPORT

C-C Chemokine Receptor Type 4

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global C-C Chemokine Receptor Type 4 Industry Growth and Trends Forecast to 2032

19 December 202589 pages

Choose your research edition.

Industry ResearchC-C Chemokine Receptor Type 4 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal C-C Chemokine Receptor Type 4 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal C-C Chemokine Receptor Type 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-C Chemokine Receptor Type 4 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C-C Chemokine Receptor Type 4 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global C-C Chemokine Receptor Type 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the C-C Chemokine Receptor Type 4 market include AstraZeneca Plc, Ono Pharmaceutical Co Ltd, Kyowa Hakko Kirin Co Ltd, Globavir Biosciences Inc, FLX Bio Inc, Corion Biotech Srl, ChemoCentryx Inc and Affitech A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global C-C Chemokine Receptor Type 4 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The C-C Chemokine Receptor Type 4 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C-C Chemokine Receptor Type 4 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C-C Chemokine Receptor Type 4.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global C-C Chemokine Receptor Type 4 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

C-C Chemokine Receptor Type 4 Market by Company

AstraZeneca Plc

Ono Pharmaceutical Co Ltd

Kyowa Hakko Kirin Co Ltd

Globavir Biosciences Inc

FLX Bio Inc

Corion Biotech Srl

ChemoCentryx Inc

Affitech A/S

C-C Chemokine Receptor Type 4 Segment by Type

K-777

GBV-3019

E-0001163

CCX-6239

Others

C-C Chemokine Receptor Type 4 Segment by Application

Central Nervous System

Immunology

Mycosis Fungoides

Others

C-C Chemokine Receptor Type 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of C-C Chemokine Receptor Type 4 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global C-C Chemokine Receptor Type 4 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global C-C Chemokine Receptor Type 4 Market Share by Region (2021-2026) Table 4. Global C-C Chemokine Receptor Type 4 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global C-C Chemokine Receptor Type 4 Market Share by Region (2027-2032) Table 6. Global C-C Chemokine Receptor Type 4 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global C-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global C-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2026) Table 9. Global C-C Chemokine Receptor Type 4 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global C-C Chemokine Receptor Type 4 Market Size Share Forecasted by Type (2027-2032) Table 11. North America C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global C-C Chemokine Receptor Type 4 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global C-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global C-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2026) Table 24. Global C-C Chemokine Receptor Type 4 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global C-C Chemokine Receptor Type 4 Market Size Share Forecasted by Application (2027-2032) Table 26. North America C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. C-C Chemokine Receptor Type 4 Industry Trends Table 37. C-C Chemokine Receptor Type 4 Industry Drivers Table 38. C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges Table 39. C-C Chemokine Receptor Type 4 Industry Restraints Table 40. Global C-C Chemokine Receptor Type 4 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Company (2021-2026) Table 42. Global C-C Chemokine Receptor Type 4 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global C-C Chemokine Receptor Type 4 Key Company Headquarters & Area Served Table 44. Global C-C Chemokine Receptor Type 4 Company, Product Type & Application Table 45. Global C-C Chemokine Receptor Type 4 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global C-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AstraZeneca Plc Company Information Table 49. AstraZeneca Plc Business Overview Table 50. AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio Table 52. AstraZeneca Plc Recent Development Table 53. Ono Pharmaceutical Co Ltd Company Information Table 54. Ono Pharmaceutical Co Ltd Business Overview Table 55. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 57. Ono Pharmaceutical Co Ltd Recent Development Table 58. Kyowa Hakko Kirin Co Ltd Company Information Table 59. Kyowa Hakko Kirin Co Ltd Business Overview Table 60. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 62. Kyowa Hakko Kirin Co Ltd Recent Development Table 63. Globavir Biosciences Inc Company Information Table 64. Globavir Biosciences Inc Business Overview Table 65. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 67. Globavir Biosciences Inc Recent Development Table 68. FLX Bio Inc Company Information Table 69. FLX Bio Inc Business Overview Table 70. FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 72. FLX Bio Inc Recent Development Table 73. Corion Biotech Srl Company Information Table 74. Corion Biotech Srl Business Overview Table 75. Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio Table 77. Corion Biotech Srl Recent Development Table 78. ChemoCentryx Inc Company Information Table 79. ChemoCentryx Inc Business Overview Table 80. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 82. ChemoCentryx Inc Recent Development Table 83. Affitech A/S Company Information Table 84. Affitech A/S Business Overview Table 85. Affitech A/S C-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio Table 87. Affitech A/S Recent Development Table 88. North America C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 90. North America C-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 91. North America C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America C-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 93. Europe C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe C-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 96. Europe C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe C-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 101. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 103. Latin America C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America C-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 106. Latin America C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America C-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 111. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. C-C Chemokine Receptor Type 4 Product Image Figure 3. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 5. Global C-C Chemokine Receptor Type 4 Market Share by Region: 2025 VS 2032 Figure 6. Global C-C Chemokine Receptor Type 4 Market Share by Region (2021-2032) Figure 7. North America C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. K-777 Image Figure 13. Global K-777 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. GBV-3019 Image Figure 15. Global GBV-3019 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. E-0001163 Image Figure 17. Global E-0001163 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. CCX-6239 Image Figure 19. Global CCX-6239 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global C-C Chemokine Receptor Type 4 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global C-C Chemokine Receptor Type 4 Market Share by Type 2025 VS 2032 Figure 24. North America C-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 25. Europe C-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 27. Latin America C-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 29. Central Nervous System Image Figure 30. Global Central Nervous System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Immunology Image Figure 32. Global Immunology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Mycosis Fungoides Image Figure 34. Global Mycosis Fungoides Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global C-C Chemokine Receptor Type 4 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global C-C Chemokine Receptor Type 4 Market Share by Application 2025 VS 2032 Figure 39. North America C-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 40. Europe C-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 42. Latin America C-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 C-C Chemokine Receptor Type 4 Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America C-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America C-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 49. Europe C-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe C-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 52. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 55. Latin America C-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America C-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 58. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • K-777
  • GBV-3019
  • E-0001163
  • CCX-6239
  • Others
Applications
  • Central Nervous System
  • Immunology
  • Mycosis Fungoides
  • Others
Companies covered
  • AstraZeneca Plc
  • Ono Pharmaceutical Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Globavir Biosciences Inc
  • FLX Bio Inc
  • Corion Biotech Srl
  • ChemoCentryx Inc
  • Affitech A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global C-C Chemokine Receptor Type 4 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global C-C Chemokine Receptor Type 4 Market Size by Region (2021-2032)
  5. 1.4.1 Global C-C Chemokine Receptor Type 4 Market Size by Region (2021-2026)
  6. 1.4.2 Global C-C Chemokine Receptor Type 4 Market Size by Region (2027-2032)
  7. 1.5 Key Regions C-C Chemokine Receptor Type 4 Market Size (2021-2032)
  8. 1.5.1 North America C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
2 C-C Chemokine Receptor Type 4 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 K-777
  3. 2.1.2 GBV-3019
  4. 2.1.3 E-0001163
  5. 2.1.4 CCX-6239
  6. 2.1.5 Others
  7. 2.2 Global C-C Chemokine Receptor Type 4 Market Size by Type
  8. 2.2.1 Global C-C Chemokine Receptor Type 4 Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global C-C Chemokine Receptor Type 4 Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global C-C Chemokine Receptor Type 4 Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global C-C Chemokine Receptor Type 4 Market Size by Regions
  12. 2.3.1 North America C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
3 C-C Chemokine Receptor Type 4 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Central Nervous System
  3. 3.1.2 Immunology
  4. 3.1.3 Mycosis Fungoides
  5. 3.1.4 Others
  6. 3.2 Global C-C Chemokine Receptor Type 4 Market Size by Application
  7. 3.2.1 Global C-C Chemokine Receptor Type 4 Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global C-C Chemokine Receptor Type 4 Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global C-C Chemokine Receptor Type 4 Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global C-C Chemokine Receptor Type 4 Market Size by Regions
  11. 3.3.1 North America C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa C-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 C-C Chemokine Receptor Type 4 Industry Trends
  2. 4.2 C-C Chemokine Receptor Type 4 Industry Drivers
  3. 4.3 C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges
  4. 4.4 C-C Chemokine Receptor Type 4 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by C-C Chemokine Receptor Type 4 Revenue (2021-2026)
  2. 5.2 Global C-C Chemokine Receptor Type 4 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global C-C Chemokine Receptor Type 4 Key Company Headquarters & Area Served
  4. 5.4 Global C-C Chemokine Receptor Type 4 Company, Product Type & Application
  5. 5.5 Global C-C Chemokine Receptor Type 4 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global C-C Chemokine Receptor Type 4 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 C-C Chemokine Receptor Type 4 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 C-C Chemokine Receptor Type 4 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AstraZeneca Plc
  2. 6.1.1 AstraZeneca Plc Company Information
  3. 6.1.2 AstraZeneca Plc Business Overview
  4. 6.1.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio
  6. 6.1.5 AstraZeneca Plc Recent Developments
  7. 6.2 Ono Pharmaceutical Co Ltd
  8. 6.2.1 Ono Pharmaceutical Co Ltd Company Information
  9. 6.2.2 Ono Pharmaceutical Co Ltd Business Overview
  10. 6.2.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  12. 6.2.5 Ono Pharmaceutical Co Ltd Recent Developments
  13. 6.3 Kyowa Hakko Kirin Co Ltd
  14. 6.3.1 Kyowa Hakko Kirin Co Ltd Company Information
  15. 6.3.2 Kyowa Hakko Kirin Co Ltd Business Overview
  16. 6.3.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  18. 6.3.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  19. 6.4 Globavir Biosciences Inc
  20. 6.4.1 Globavir Biosciences Inc Company Information
  21. 6.4.2 Globavir Biosciences Inc Business Overview
  22. 6.4.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio
  24. 6.4.5 Globavir Biosciences Inc Recent Developments
  25. 6.5 FLX Bio Inc
  26. 6.5.1 FLX Bio Inc Company Information
  27. 6.5.2 FLX Bio Inc Business Overview
  28. 6.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio
  30. 6.5.5 FLX Bio Inc Recent Developments
  31. 6.6 Corion Biotech Srl
  32. 6.6.1 Corion Biotech Srl Company Information
  33. 6.6.2 Corion Biotech Srl Business Overview
  34. 6.6.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio
  36. 6.6.5 Corion Biotech Srl Recent Developments
  37. 6.7 ChemoCentryx Inc
  38. 6.7.1 ChemoCentryx Inc Company Information
  39. 6.7.2 ChemoCentryx Inc Business Overview
  40. 6.7.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio
  42. 6.7.5 ChemoCentryx Inc Recent Developments
  43. 6.8 Affitech A/S
  44. 6.8.1 Affitech A/S Company Information
  45. 6.8.2 Affitech A/S Business Overview
  46. 6.8.3 Affitech A/S C-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio
  48. 6.8.5 Affitech A/S Recent Developments
7 North America
  1. 7.1 North America C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 7.3 North America C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 8.3 Europe C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 10.3 South America C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst